SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 99.45 |
| Enterprise Value ($M) | 37.79 |
| Book Value ($M) | 257.16 |
| Book Value / Share | 4.19 |
| Price / Book | 0.39 |
| NCAV ($M) | 223.59 |
| NCAV / Share | 3.64 |
| Price / NCAV | 0.44 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.69 |
| Return on Assets (ROA) | -0.42 |
| Return on Equity (ROE) | -0.50 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 11.03 |
| Current Ratio | 11.03 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 311.19 |
| Assets | 344.77 |
| Liabilities | 87.61 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -228.37 |
| Net Income | -210.30 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -155.50 |
| Cash from Investing | 140.34 |
| Cash from Financing | 23.12 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Paradigm Biocapital Advisors LP | 0.00 | -100.00 | |
| 13G/A | Price T Rowe Associates Inc /md/ | 0.10 | -98.19 | |
| 13D | Tang Capital Management Llc | 9.60 | ||
| 13G/A | Fmr Llc | 0.20 | -96.67 | |
| 13G/A | Redmile Group, LLC | 4.80 | -9.45 | |
| 13G/A | First Light Asset Management, LLC | 3.21 | -46.94 | |
| 13G/A | Blue Owl Capital Holdings LP | 4.94 | 0.00 | |
| 13G/A | Laurion Capital Management LP | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 161,800 | 698,171 | 23.17 | |
| 228,446 | 900,703 | 25.36 | |
| 90,116 | 1,245,447 | 7.24 | |
| 222,333 | 1,507,440 | 14.75 | |
| 138,324 | 1,242,686 | 11.13 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PGEN – Precigen, Inc. | PHAT – Phathom Pharmaceuticals, Inc. |
| PHVS – Pharvaris N.V. | PMVP – PMV Pharmaceuticals, Inc. |
| PRAX – Praxis Precision Medicines, Inc. |
Financial data and stock pages provided by
Fintel.io